Limbic-cortical neuronal damage and the pathophysiology of schizophrenia

Schizophrenia Bulletin

Volumn 24, Issue 2, 1998, Pages 231-248

  Csernansky, John G ^a   Bardgett, Mark E ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antipsychotic drugs; Dopamine; Hippocampus

Indexed keywords

DOPAMINE 2 RECEPTOR;

CORPUS STRIATUM; DOPAMINERGIC SYSTEM; HIPPOCAMPUS; HUMAN; LIMBIC CORTEX; NERVE PROJECTION; NEUROPATHOLOGY; NUCLEUS ACCUMBENS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0031782171     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033323     Document Type: Review

References (143)

1. Altshuler, L.L.; Casanova, M.F.; Goldberg, T.E.; and Kleinman, J.E. The hippocampus and parahippocampus in Schizophrenic, suicide, and control brains. Archives of General Psychiatry, 47:1029-1034, 1990.
2. Andreasen, N.C.; Arndt, S.; Alliger, R.; Miller, D.; and Flaum, M. Symptoms of schizophrenia:Methods, meanings, and mechanisms. Archives of General Psychiatry, 52:341-351, 1995.
3. Andreasen, N.C.; Nasrallah, H.A.; Dunn, V.; Olson, S.C.; Grove, W.M.; Ehrhardt, J.C.; Coffman, J.A.; and Crossett, J.H.W. Structural abnormalities in the frontal system in schizophrenia:A magnetic resonance imaging study. Archives of General Psychiatry, 43:136-144, 1986.
4. Andreasen, N.C.; Olsen, S.A.; Dennert, J.W.; and Smith, M.R. Ventricular enlargement in schizophrenia:Relationship to positive and negative symptoms. American Journal of Psychiatry, 139:297-302, 1982.
5. Arndt, S.; Andreasen, N.C.; Flaum, M.; Miller, D.; and Nopoulos, P. A longitudinal study of symptom dimensions in schizophrenia. Archives of General Psychiatry, 52:352-360, 1995.
6. Arnold, S.E.; Hyman, B.T.; Van Hoesen, G.W.; and Damasio, A.R. Some cytoarchitectural abnormalities of the entorhinal cortex in schizophrenia. Archives of General Psychiatry, 48:625-632, 1991.
7. Asper, H.; Baggiolini, M.; Burki, H.R.; Lauener, H.; Ruch, W.; and Stille, G. Tolerance phenomena with neuroleptics:Catalepsy, apomorphine stereotypies, and striatal dopamine metabolites in the rat after single and repeated administration of loxapine and haloperidol. European Journal of Pharmacology, 22:287-294, 1973.
8. Bannon, M.J.; Bunney, E.B.; Zigun, J.R.; Skirboll, L.R.; and Roth, R.H. Presynaptic dopamine receptors:Insensitivity to kainic acid and the development of supersensitivity following chronic haloperidol. Naunyn-Schmiedeberg's Archives of Pharmacology, 312:161-165, 1980.
9. Bardgett, M.E., and Csemansky, J.G. Antipsychotic drugs and neuronal injury. In:Csernansky, J.G., ed. Handbook of Experimental Pharmacology. Berlin, Germany:Springer-Verlag, 1996. pp. 267-288.
10. Bardgett, M.E.; Jackson, J.L.; and Csernansky, J.G. "Limbic-Cortical Lesions Attenuate Stimulation-Induced Glutamate and Dopamine Release in the Nucleus Accumbens." Presented at the 34th Annual Meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 1995a.
11. Bardgett, M.E.; Jackson, J.L.; Taylor, G.T.; and Csernansky, J.G. Kainic acid decreases hippocampal neuronal number and increases dopamine receptor binding in the nucleus accumbens:An animal model of schizophrenia. Behavioral Brain Research, 70:153-164, 1995b.
12. Bardgett, M.E.; Jacobs, P.; Ratanasadudi, A.; and Csernansky, J.G. Schizophrenia-like hippocampal neuropathy in rats:Enhanced sensitivity to stress, d-amphetamine, and MK-801. [Abstract] Society for Neuroscience Abstracts, 21:238, 1995c.
13. Bardgett, M.E.; Salaris, S.L.; Jackson, J.L.; Harding, J.; and Csemansky, J.G. The effects of kainic acid lesions on dopaminergic responses to haloperidol and clozapine. Psychopharmacology, 133(2):142-151, 1997.
14. Barta, P.E.; Pearlson, G.D.; Powers, R.E.; Richards, S.S.; and Tune, L.E. Auditory hallucinations and smaller superior temporal lobe volume in schizophrenia. American Journal of Psychiatry, 147:1457-1462, 1990.
15. Bartley, A.J.; Jones, D.W.; Torrey, E.F.; Zigun, J.R.; and Weinberger, D.R. Sylvian fissure asymmetries in monozygotic twins:A test of laterality in schizophrenia. Biological Psychiatry, 34:853-863, 1993.
16. Benes, F.M., and Bird, E.D. An analysis of the arrangement of neurons in the cingulate cortex of schizophrenic patients. Archives of General Psychiatry. 44:608-616, 1987.
17. Benes, F.M.; Davidson, J.; and Bird, E.D. Quantitative cytoarchitectural studies of cerebral cortex of schizophrenic patients. Archives of General Psychiatry, 44:608-616, 1986.
18. Benes, P.M.; McSparren, J.; Bird, E.D.; SanGiovanni, J.P.; and Vincent, S.L. Deficits in the interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Archives of General Psychiatry, 48:996-1001, 1991a.
19. Benes, P.M.; Sorensen, I.; and Bird, E.D. Reduced neuronal size in posterior hippocampus of schizophrenic patients. Schizophrenia Bulletin. 17(4):597-608, 1991 b.
20. A receptor binding in superficial layers of cingulate cortex in schizophrenics. Journal of Neuroscience, 12:924-929, 1992.
21. Bloom, F.E. Advancing a neurodevelopmental origin for schizophrenia. Archives of General Psychiatry, 50:224-227, 1993.
22. Bogerts, B.; Ashtari, M.; Degreef, G.; Alvir, J.M.J.; Bilder, R.M.; and Lieberman, J.A. Reduced temporal limbic structure volumes on magnetic resonance images in first episode schizophrenia. Psychiatry Research, 35:1-13,1990.
23. Bogerts, B.; Lieberman, J.A.; Ashtari, M.; Bilder, R.M.; Degreef, G.; Lerner, G.; John, C.; and Masiar, S. Hippocampus-amygdala volumes and psychopathology in chronic schizophrenia. Biological Psychiatry, 33:236-246, 1993.
24. Bowers, M.B., and Heninger, G.F. CSF HVA patterns during neuroleptic treatment. Psychiatry Research, 4:285-290, 1981.
25. Bowers, M.B., and Hoffman, F.J. Homovanillic acid in caudate and prefrontal cortex following acute and chronic neuroleptic administration. Psychopharmacology, 88:63-65, 1986.
26. Bowers, M.B.; Swigar, M.E.; Jatlow, P.I.; and Goicoechea, N. Plasma catecholamine metabolites and early response to haloperidol. Journal of Clinical Psychiatry, 45:248-251, 1984.
27. Bowers, M.B.; Swigar, M.E.; Jatlow, P.I.; Hoffman, F.; and Goicoechea, N. Early neuroleptic response:Clinical profiles and plasma catecholamine metabolites. Journal of Clinical Psychopharmacology, 7:83-86, 1987.
28. Bracha, H.S. Etiology of structural asymmetry in schizophrenia:An alternative hypothesis. [Letter] Schizophrenia Bulletin, 17(4):551-553, 1991.
29. Breier, A.; Buchanan, R.W.; Elkashef, A.; Munson, R.C.; Kirkpatrick, B.; and Gellad, F. Brain morphology and schizophrenia:A magnetic resonance imaging study of limbic, prefrontal cortex, and caudate structures. Archives of General Psychiatry, 49:921-926, 1992.
30. Brodie, J.D.; Christman, D.R.; Corona, J.F.; Fowler, J.S.; Gomez-Mont, F.; Jaeger, J.; Michels, P.A.; Rotrosen, J.; Russell, J.A.; Volkow, N.D.; Wickler, A.; Wolf, A.P.; and Wolkin, A. Patterns of metabolic activity in the treatment of schizophrenia. Annals of Neurology, 15(Suppl.):166-169, 1984.
31. Brown, R.; Colter, N.; Corsellis, J.A.N.; Crow, T.J.; Frith, C.D.; Jagoe, R.; Johnstone, E.C.; and Marsh, L. Postmortem evidence of structural brain changes in schizophrenia:Differences in brain weight, temporal horn area, and parahippocampal gyrus compared to affective disorder. Archives of General Psychiatry, 43:36-42, 1986.
32. Buchanan, R.W.; Breier, A.; Kirkpatrick, B.; Elkashef, A.; Munson, R.C.; Gellad, F.; and Carpenter, W.T., Jr. Structural abnormalities in deficit and nondencit schizophrenia. American Journal of Psychiatry, 150(1 ):59-65, 1993.
33. Buchsbaum, M.S.; DeLisi, L.E.; Holcomb, H.H.; Cappelletti, J.; King, A.C.; Johnson, J.; Hazlett, E.; Dowling-Zimmerman, S.; Post, R.M.; Morihisa, J.; Carpenter, W.T., Jr.; Cohen, R.; Pickar, D.; Weinberger, D.R.; Margolin, R.; and Kessler, R.M. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archives of General Psychiatry, 41(12):1159-1166, 1984.
34. Buchsbaum, M.S.; Haier, R.J.; Potkin, S.G.; Nuechterlein, K.; Bracha, H.S.; Katz, M.; Lohr, J.; Wu, J.; Lottenberg, S.; Jerabek, P.A.; Trenary, M.; Tafalla, R.; Reynolds, C.; and Bunney, W.E. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Archives of General Psychiatry, 49:935-942, 1992.
35. Bunney, B.S. Effects of acute and chronic neuroleptic treatment on the activity of midbrain dopamine neurons. Annals of the New York Academy of Science, 537:77-85, 1988.
36. Carlsson, M., and Carlsson, A. Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease. Trends in Neuroscience, 13(7):272-276, 1990.
37. Cavazos, J.E.; Golarai, G.; and Sutula, T.P. Mossy fiber synaptic reorganization induced by kindling:Time course of development, progression, and permanence. Journal of Neuroscience, 11:2795-2803, 1991.
38. Cavazos, J.E., and Sutula, T.P. Progressive neuronal loss induced by kindling:A possible mechanism for mossy fiber synaptic reorganization and hippocampal sclerosis. Brain Research, 527:1-6, 1990.
39. Chang, W.-H.; Chen, T.-Y.; Lin, S.-K.; Lung, F.-W.; Lin, W.-L.; Hu, W.-H.; and Yeh, E.-K. Plasma catecholamine metabolites in schizophrenics:Evidence for the two-subtype concept. Biological Psychiatry, 27:510-518, 1990.
40. Chang, W.-H.; Yeh, E.-K.; Hu, W.-H.; Tseng, Y.-T.; Chung, M.-C; and Chang, H.-F. Acute and chronic effects of haloperidol on plasma and brain homovanillic acid in the rat. Biological Psychiatry, 21:374-381, 1986.
41. Charriaut-Marlangue, C.; Aggoun-Zouaoui, D.; Represa, A.; and Ben-Ari, Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends in Neuroscience, 19:109-114, 1996.
42. Conrad, A.J.; Abebe, T.; Austin, R.; Forsythe, S.; and Scheibel, A.B. Hippocampal pyramidal cell disarray in schizophrenia as a bilateral phenomenon. Archives of General Psychiatry, 48:413-417, 1991.
43. Conrad, A.J., and Scheibel, A.B. Schizophrenia and the hippocampus:The embryological hypothesis extended. Schizophrenia Bulletin, 13(4):577-587, 1987.
44. Crow, T.J. Temporal lobe asymmetries as the key to the etiology of schizophrenia. Schizophrenia Bulletin, 16:433-443, 1990.
45. Crow, T.J.; Ball, J.; Bloom, S.R.; Brown, R.; Bruton, C.J.; Colter, N.; Frith, C.D.; Johnstone, E.G.; Owens, D.G.C.; and Roberts, G.W. Schizophrenia as an anomaly of development of cerebral asymmetry:A postmortem study and a proposal concerning the genetic basis of the disease. Archives of General Psychiatry, 46:1145-1150, 1989.
46. Csernansky, J.G.; Bellows, E.P.; Barnes, D.; and Lombrozo, L. Sensitization versus tolerance to the dopamine turnover-elevating effects of haloperidol:The effect of regular/intermittent dosing. Psychopharmacology, 101:519-524, 1990.
47. Csernansky, J.G.; Kaplan, J.; and Hollister, L.E. Problems in the classification of schizophrenics as neuroleptic responders and nonresponders. Journal of Nervous and Mental Disease, 173:325-331, 1985.
48. Csernansky, J.G.; Kerr, S.; Pruthi, R.; and Prosser, E.S. Mesolimbic dopamine receptor increases two weeks following hippocampal kindling. Brain Research, 449:357-360, 1988a.
49. Csernansky, J.G.; Mellentin, J.; Beauclair, L.; and Lombrozo, L. Mesolimbic dopaminergic supersensitivity following electrical kindling of the amygdala. Biological Psychiatry, 23:285-294, 1988b.
50. Csernansky, J.G.; Murphy, G.M.; and Faustman, W.O. Limbic/mesolimbic connections and the pathogenesis of schizophrenia. Biological Psychiatry, 30:383-400, 1991.
51. Csernansky, J.G.; Wrona, C.T.; Bardgett, M.E.; Early, T.S.; and Newcomer, J.W. Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology, 110:145-151, 1993.
52. Dauphinais, I.D.; DeLisi, L.E.; Crow, T.J.; Alexandropoulos, K.; Colter, N.; Tuma, I.; and Gershon, E.S. Reduction in temporal lobe size in siblings with schizophrenia:A magnetic resonance imaging study. Psychiatry Research, 35:137-147, 1990.
53. Davidson, M.; Kahn, R.S.; Knott, P.; Kaminsky, R.; Cooper, M.; DuMont, K.; Apter, S.; and Davis, K.L. The effect of neuroleptic treatment on plasma homovanillic acid concentrations and schizophrenic symptoms. Archives of General Psychiatry, 48:910-913, 1991.
54. Davila, R.; Manero, E.; Zumarrage, M.; Andia, I.; Schweitzer, J.; and Friedhoff, A.J. Plasma homovanillic acid as a predictor of response to neuroleptics. Archives of General Psychiatry, 45:564-567, 1988.
55. Degreef, G.; Ashtari, M.; Bogerts, B.; Bilder, R.M.; Jody, D.N.; Alvir, J.M.; and Lieberman, J.A. Volumes of ventricular system subdivisions measured from magnetic resonance images in first-episode schizophrenic patients. Archives of General Psychiatry, 49(7):531-537, 1992.
56. DeLisi, L.E.; Buchsbaum, M.S.; Holcomb, H.H. owling-Zimmerman, S.; Pickar, D.; Boronow, J. Morihisa, J.M.; van Kammen, D.P.; Carpenter, W.T., Jr. Kessler, R.; Margolin, R.; and Cohen, R.M. Clinical correlates of decreased anteroposterior gradients in positron emission tomography (PET) of schizophrenic patients. American Journal of Psychiatry, 142(1):78-81, 1985.
57. DeLisi, L.E.; Hoff, A.L.; Neale, C.; and Kushner, M. Asymmetries in the superior temporal lobe in male and female first-episode schizophrenic patients:Measures of the planum temporale and superior temporal gyrus by MRI. Schizophrenia Research, 12:19-28, 1994.
58. DeLisi, L.E.; Stritzke, P.; Riordan, H.; Holan, V.; Boccio, A.; Kushner, M.; McClelland, J.; Van Eyl, O.; and Anand, A. The timing of brain morphological changes in schizophrenia and their relationship to clinical outcome. Biological Psychiatry, 31(3):241-254, 1992.
59. Falkai, P., and Bogerts, B. Cell loss in the hippocampus of schizophrenics. European Archives of Psychiatry and Neurological Sciences, 236:154-161, 1986.
60. Farkas, T.; Wolf, A.P.; Jaeger, J.; Brodie, J.D.; Christman, D.R.; and Fowler, J.S. Regional brain glucose metabolism in chronic schizophrenia:A positron emission transaxial tomographic study. Archives of General Psychiatry, 41:293-300, 1984.
61. Flaum, M.; Swayze, V.W.; O'Leary, D.S.; Yuh, W.T.C.; Ehrhardt, J.C.; Arndt, S.V.; and Andreasen, N.C. Effects of diagnosis, laterality, and gender on brain morphology in schizophrenia. American Journal of Psychiatry, 152:704-714, 1995.
62. Foster, A.C.; Mena, E.E.; Monaghan, D.T.; and Cotman, C.W. Synaptic localization of kainic acid binding sites. Nature, 289:73-75, 1981.
63. Fox, N.C.; Freeborough, P.A.; and Rossor, M.N. Visualization and quantification of rates of atrophy in Alzheimer's disease. Lancet, 348:94-97, 1996.
64. Friedhoff, A.J. Dopamine as a mediator of a central stabilizing system. Neuropsychopharmacology, 1:189-191, 1988.
65. Galaburda, A.M. Asymmetries of cerebral neuroanatomy. In:Biological Asymmetry and Handedness. Ciba Foundation Symposium 162. Chichester, England:John Wiley & Sons, 1991. pp. 219-233.
66. Galaburda, A.M.; Corsiglia, J.; Rosen, G.D.; and Sherman, G.F. Plànum temporale asymmetry, reappraisal since Geschwind and Levitsky. Neuropsychologia, 25:853-868, 1987.
67. Geschwind, N., and Levitsky, W. Human brain:Left-right asymmetries in temporal speech region. Science, 161:186-187,1968.
68. Giedd, J.N.; Vaituzis, A.C.; Hamburger, S.D.; Lange, N.; Rajapakse, J.C.; Kaysen, D.; Vauss, Y.C.; and Garrick, N. Quantitative MRI of the temporal lobe, amygdala, and hippocampus in normal human development:Ages 4-18. [Abstract] Society for Neuroscience Abstracts, 21:154, 1995.
69. Grace, A.A. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity:A hypothesis for the etiology of schizophrenia. Neuroscience, 41:1-24, 1991.
70. Heaton, R.K., and Crowley, T.J. Effects of psychiatric disorders and their somatic treatment on neuropsychological test results. In:Filskov, S.V., and Toll, T.J., eds. Handbook of Clinical Neuropsychology. New York, NY:John Wiley & Sons, 1981. pp. 481-525.
71. Heckers, S.; Heinsen, H.; Geiger, B.; and Beckmann, H. Hippocampal neuron number in schizophrenia:A stereological study. Archives of General Psychiatry, 48:1002-1008, 1991.
72. Heckers, S.; Heinsen, H.; Heinsen, Y.C.; and Beckmann, H. Limbic structures and lateral ventricle in schizophrenia:A quantitative postmortem study. Archives of General Psychiatry, 47:1016-1020, 1990.
73. Jakob, H., and Beckmann, H. Prenatal developmental disturbances in the limbic allocortex in schizophrenics. Journal of Neural Transmission, 65:303-326, 1986.
74. 2 receptor regulation unilaterally [Abstract]. Society for Neuroscience Abstracts, 242:11, 1991.
75. Jarrard, L.E. Selective hippocampal lesions and behavior:Effects of kainic acid lesions on performance of place and cue tasks. Behavioral Neuroscience, 97:873-889, 1982.
76. Jaskiw, G.E.; Tizabe, Y.; Lipska, B.K.; Kolachana, B.S.; Wyan, R.J.; and Gilad, G.M. Evidence for frontalcorticalseptal glutamatergic pathway and compensatory changes in septal glutamate uptake after cortical and fornix lesions in the rat. Brain Research, 550:7-10, 1991.
77. Javaid, J.I.; Sharma, R.; Janicak, P.; and Davis, J.M. Plasma HVA in psychiatric patients:Longitudinal studies. Psychopharmacology Bulletin, 26(3):361-365, 1990.
78. Javitt, D.C., and Zukin, S.R. Recent advances in the phencyclidine model of schizophrenia. American Journal of Psychiatry, 148:1301-1308, 1991.
79. Jeste, D.V., and Lohr, J.B. Hippocampal pathologic findings in schizophrenia:A morphometric study. Archives of General Psychiatry, 46:1019-1024, 1989.
80. Johnstone, E.G.; Crow, T.J.; Frith, C.D.; Husband, J.; and Kreel, L. Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet, 11:924-926, 1976.
81. Johnstone, E.G.; Owens, D.G.C.; Crow, T.J.; Frith, C.D.; Alexandropolis, K.; Bydder, G.; and Colter, N. Temporal lobe structure as determined by nuclear magnetic resonance in schizophrenia and bipolar affective disorder. Journal of Neurology, Neurosurgery and Psychiatry, 52:736-741, 1989.
82. Kane, J.; Honigfeld, G.; Singer, J.; and Meltzer, H. Clozapine for the treatment-resistant schizophrenic:A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45(9):789-796, 1988.
83. Kawazaki, Y.; Maeda, Y.; Urata, K.; Higashima, M.; Yamaguchi, N.; Suzuki, M.; Takashima, T.; and Ide, Y. Quantitative magnetic resonance imaging study of patients with schizophrenia. European Archives of Psychiatry and Clinical Neuroscience, 242:268-272, 1993.
84. Kerwin, R.; Patel, S.; and Meldrum, B. Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post-mortem. Neuroscience, 39:25-32, 1990.
85. Kikinis, R.; Shenton, M.E.; Gerig, G.; Hokama, H.; Haimson, J.; O'Donnell, C.F.; Wible, C.G.; McCarley, R.W.; and Jolesz, F.A. Temporal lobe sulco-gyral pattern anomalies in schizophrenia:An in vivo MR three-dimensional surface rendering study. Neuroscience Letters, 182:7-12, 1994.
86. Kling, A.S.; Metter, E.J.; Reige, W.H.; and Kuhl, D.E. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. American Journal of Psychiatry, 143:175-180, 1986.
87. Kovelman, J., and Scheibel, A.B. A neurohistological correlate of schizophrenia. Biological Psychiatry, 19:1601-1621, 1984.
88. Krystal, J.H.; Karper, L.P.; Siebyl, J.P.; Freeman, G.K.; Delaney, R.; Brenmer, J.D.; Heninger, G.R.; Bowers, M.B.; and Charney, D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans:Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Archives of General Psychiatry, 51:199-214, 1994.
89. Lipska, B.K.; Jaskiw, G.E.; Chrapusta, S.; Karoum, F.; and Weinberger, D.R. Ibotenic lesion of the ventral hippocampus differentially affects dopamine and its metabolites in the nucleus accumbens and prefrontal cortex in the rat. Brain Research, 585:1-6, 1992.
90. Lipska, B.K.; Jaskiw, G.E.; Karoum, F.; Phillips, I.; Kleinman, J.E.; and Weinberger, D.R. Dorsal hippocampal lesion does not affect dopaminergic indices in the basal ganglia. Pharmacology, Biochemistry and Behavior, 40:181-184, 1991.
91. Lopes da Silva, F.H.; Witter, M.P.; Boeijinga, P.H.; and Lohman, A.H.M. Anatomic organization and physiology of the limbic cortex. Physiological Reviews, 70:453-511, 1990.
92. Luchins, D.J.; Weinberger, D.R.; and Wyatt, R.J. Schizophrenia and cerebral asymmetry detected by computed tomography. American Journal of Psychiatry, 139:753-757, 1982.
93. Margolis, R.L.; Chaung, D.M.; and Post, R.M. Programmed cell death:Implications for neuropsychiatric disorders. Biological Psychiatry, 35:946-956, 1994.
94. Marsh, L.; Suddath, R.L.; Higgins, N.; and Weinberger, D.R. Medial temporal lobe structures in schizophrenia:Relationship of size to duration of illness. Schizophrenia Research, 11:225-238, 1994.
95. Mazure, C.M.; Nelson, C.J.; Jatlow, P.I.; and Bowers, M.B. Plasma free homovanillic acid as a predictor of clinical response in acute psychosis. Biological Psychiatry, 30:475-482, 1991.
96. McCarley, R.W.; Shenton, M.E.; O'Donnell, B.F.; Faux, S.F.; Kikinis, R.; Nestor, P.O.; and Jolesz, F.A. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Archives of General Psychiatry, 50:190-197, 1993.
97. Menon, R.R.; Barta, P.E.; Aylward, E.H.; Richards, S.S.; Vaughn, D.D.; Tien, A.Y.; Harris, GJ.; and Pearlson, G.D. Posterior superior temporal gyrus in schizophrenia:Gray matter changes and clinical correlates. Schizophrenia Research, 16:127-135, 1995.
98. Nadler, J.V.; Perry, B.W.; and Cotman, C.W. Preferential vulnerability of hippocampus intraventricular kainic acid. In:McGeer, E.G.; Olney, J.W.; and McGeer, PL., eds. Kainic Acid as a Tool in Neurobiology. New York, NY:Raven Press, 1978. pp. 219-237.
99. Nadler, J.V.; Perry, B.W.; and Cotman, C.W. Selective reinnervation of hippocampal area CA1 and the fascia dentata after destruction of CA3-CA4 afferents with kainic acid. Brain Research, 182:1-9, 1980.
100. Nakajima, S.; Franck, J.E.; Bilkey, D.; and Schwartzkoin, P.A. Local circuit synaptic interactions between CA1 pyramidal cells and interneurons in the kainate-lesioned hyperexcitable hippocampus. Hippocampus, 1:67-78, 1991.
101. Nestor, P.G.; Shenton, M.E.; McCarley, R.W.; Haimson, J.; Smith, S.; O'Donnell, B.; Kimble, M.; Kikinis, R.; and Jolesz, F.A. Neuropsychological correlates of MRI temporal lobe abnormalities in schizophrenia. American Journal of Psychiatry, 150:1849-1855, 1993.
102. Nitsch, C.; Kim, J.-K.; Shimade, C.; and Okada, Y. Effect of hippocampal extirpation in the rat on glutamate levels in target structures of hippocampal efferents. Neuroscience Letters, 11:295-299, 1979.
103. Nowak, J.Z.; Arbilla, S.; Galzin, A.M.; and Langer, S.Z. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol. Journal of Pharmacology and Experimental Therapeutics, 226:558-564, 1983.
104. 2-mediated attenuation of cortical excitation in nucleus accumbens neurons recorded in vitro. Brain Research, 634:105-112, 1994.
105. O'Donnell, P., and Grace, A.A. Synaptic interactions among excitatory afferents to nucleus accumbens neurons:Hippocampal gating of prefrontal cortical input. Journal of Neuroscience, 15:3622-3639, 1995.
106. Olney, J.W., and Farber, N.B. Glutamate receptor dysfunction and schizophrenia. Archives of General Psychiatry, 52(12):998-1007, 1995.
107. Olney, J.W.; Rhee, V.; and Ho, O.L. Kainic acid:A powerful neurotoxic analogue of glutamate. Brain Research, 77:507-512, 1974.
108. Overall, J.E., and Gorham, D.R. The Brief Psychiatric Rating Scale. Psychological Reports, 10:799-812, 1962.
109. Pearlson, G.D., and Marsh, L. Magnetic resonance imaging in psychiatry. In:Oldham, J.; Riba, M.B.; and Tasman, A., eds. Annual Review of Psychiatry. Vol. 12. Washington, DC:American Psychiatric Press, 1993. pp. 347-382.
110. Petrie, E.C.; Faustman, W.O.; Moses, J.A.; Lombrozo, L.; and Csernansky, J.G. Correlates of rapid neuroleptic response in male patients with schizophrenia. Psychiatry Research, 33:171-177, 1990.
111. Pickar, D.; Labarca, R.; Doran, A.R.; Wolkowitz, O.M.; Roy, A.; Breier, A.; Linnoila, M.; and Paul, S.M. Longitudinal measurement of plasma homovanillic acid levels in schizophrenic patients. Archives of General Psychiatry, 43:669-676, 1986.
112. Pickar, D.; Labarca, R.; Linnoila, M.; Roy, A.; Hommer, D.V.; Erettet, D.; and Paul, S.M. Neuroleptic-induced decrease in plasma homovanillic acid levels in schizophrenic patients. Science, 225:954-957, 1984.
113. Roberts, G.W. Schizophrenia:The cellular biology of a functional psychosis. Trends in Neuroscience, 13:207-211, 1990.
114. Rossi, A.; Stratta, P.; Mancini, F.; Gallucci, M.; Mattei, P.; Core, L.; Di Michele, V.; and Casacchia, M. Magnetic resonance imaging findings of amygdala-anterior hippocampus shrinkage in male patients with schizophrenia. Psychiatry Research, 52:43-53, 1994.
115. Salaris, S.; Bardgett, M.E.; Jackson, J.; and Csernansky, J.G. Schizophrenia-like hippocampal neuropathy in rats:Dopaminergic response to acute clozapine in the accumbens shell. [Abstract] Society for Neuroscience Abstracts, 21:238, 1995.
116. Saller, C.F., and Salama, A.I. Alterations in dopamine metabolism after chronic administration of haloperidol. Neuropharmacology, 24:123-129, 1985.
117. Sayers, A.C.; Burki, H.R.; Ruch, W.; and Asper, H. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesia:Effects of clozapine, haloperidol, loxapine, and chlorpromazine. Psychopharmacologia, 41:97-104, 1975.
118. Scatton, B. Effect of repeated treatment with neuroleptics on dopamine metabolism in cell bodies and terminals of dopaminergic systems in the rat brain. Advances in Biochemical Psychopharmacology, 24:31-36, 1980.
119. Seidman, L.J.; Yurgelun-Todd, D.; Kremen, W.S.; Woods, B.T.; Goldstein, J.M.; Faraone, S.V.; and Tsuang, M.T. Relationship of prefrontal and temporal lobe MRI measures to neuropsychological performance in chronic schizophrenia. Biological Psychiatry, 35:235-246, 1994.
120. Selemon, L.D.; Rajkowska, G.; and Goldman-Rakic, P.S. Abnormally high neuronal density in the schizophrenic cortex. Archives of General Psychiatry, 52:805-818, 1995.
121. Sesack, S.R.; Deutch, A.Y.; Roth, R.H.; and Bunney, B.S. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat:An anterograde tracttracing study with phaseolus vulgaris leucoagglutinin. Journal of Comparative Neurology, 290:213-242, 1989.
122. Sharma, R.; Javaid, J.I.; Janicak, P.; Faull, K.F.; Comaty, J.; and Davis, J.M. Plasma and CSF HVA before and after pharmacological treatment. Psychiatry Research, 28:97-104, 1989.
123. Shenton, M.E.; Kikinis, R.; Jolesz, F.A.; Pollak, S.D.; LeMay, M.; Wible, C.G.; Hokama, H.; Martin, J.; Metcalf, D.; Coleman, M.; and McCarley, R.W. Abnormalities of the left temporal lobe and thought disorder in schizophrenia. New England Journal of Medicine, 327:604-612, 1992.
124. Sloviter, R.S. Permanently altered hippocampal structure, excitability, and inhibition after experimental status epilepticus in the rat:The "dormant basket cell" hypothesis and its possible relevance to temporal lobe epilepsy. Hippocampus, 1:41-66, 1991.
125. Springer, J.E., and Issacson, R.L. Catecholamine alterations in basal ganglia after hippocampal lesions. Brain Research, 252:185-188, 1982.
126. Stern, R.G.; Kahn, R.S.; and Davidson, M. Predictors of response to neuroleptic treatment in schizophrenia. Psychiatric Clinics of North America, 16:313-338, 1993.
127. Stevens, J.R. Abnormal reinnervation as a basis for schizophrenia:A hypothesis. Archives of General Psychiatry, 49:238-243, 1992.
128. Suddath, R.L.; Casanova, M.F.; Goldberg, T.E.; Daniel, D.G.; Kelsoe, J.R.; and Weinberger, D.R. Temporal lobe pathology in schizophrenia:A quantitative MRI study. American Journal of Psychiatry, 146:464-472, 1989.
129. Suddath, R.L.; Christison, G.W.; Torrey, E.F.; Casanova, M.F.; and Weinberger, D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine, 322:789-794, 1990.
130. Sutula, T.; Xiao-Xian, H.; and Cavazos, S.G. Synaptic reorganization in the hippocampus induced by abnormal functional activity. Science, 239:1147-1150,1988.
131. Swayze, V.W.; Andreasen, N.C.; Alliger, R.J.; Yuh, W.T.C.; and Ehrhardt, J.C. Subcortical and temporal structures in affective disorder and schizophrenia:A MRI study. Biological Psychiatry, 31:221-240, 1992.
132. Taber, M.T.; Das, S.; and Fibiger, H.C. Cortical regulation on subcortical dopamine release:Mediation via the ventral tegmental area. Journal of Neurochemistry, 65:1407-1410, 1995.
133. Tauck, D.L., and Nadler, J.V. Evidence of functional mossy fiber sprouting in hippocampal formation of kainic acid-treated rats. Journal of Neuroscience, 5:1016-1022, 1985.
134. van Putten, T.; Marder, S.; Aravagiri, M.; Chabert, H.; and Mintz, J. Plasma homovanillic acid as a predictor of response to fluphenazine treatment. Psychopharmacology Bulletin, 25(1):89-91, 1989.
135. Walaas, I., and Fonnum, F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience, 5:1691-1698, 1980.
136. Weinberger, D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Archives of General Psychiatry, 44:660-669, 1987.
137. Weinberger, D.R.; Berman, K.F.; Suddath, R.; and Torrey, E.F. Evidence of dysfunction of a prefrontal-limbic network in schizophrenia:A magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins. American Journal of Psychiatry, 149:890-897, 1992.
138. Werner, P.; Voigt, M.; Keinanen, K.; Widsen, W.; and Seeburg, P.H. Cloning of a putative high-affinity kainate receptor expressed predominantly in hippocampal CA3 cells. Nature, 351:742-744, 1991.
139. Wolkin, A.; Jaeger, J.; Brodie, J.D.; Wolf, A.P.; Fowler, J.S.; Rotrosen, J.; Gomez-Mont, F.; and Cancro, R. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. American Journal of Psychiatry, 142:564-571, 1985.
140. Young, A.H.; Blackwood, D.H.R.; Roxborough, H.; McQueen, J.K.; Martin, M.J.; and Kean, D. A magnetic resonance imaging study of schizophrenia:Brain structure and clinical symptoms. British Journal of Psychiatry, 158:158-164,1991.
141. Zaczek, R.; Hedreen, J.C.; and Coyle, J.T. Evidence for a hippocampal-septal glutamatergic pathway in the rat. Experimental Neurology, 65:145-156, 1979.
142. Zipursky, R.B.; Lim, K.O.; Sullivan, E.V.; Brown, B.W.; and Pfefferbaum, A. Widespread cerebral gray volume deficits in schizophrenia. Archives of General Psychiatry, 49:195-205, 1992.
143. Zipursky, R.B.; Marsh, L.; Lim, K.O.; DeMent, S.; Shear, P.K.; Sullivan, E.V.; Murphy, G.M.; Csernansky, J.G.; and Pfefferbaum, A. Volumetric MRI assessment of temporal lobe structures in schizophrenia. Biological Psychiatry, 35:501-516, 1994.